In 2024, INKON Life Technology generated a net profit of 83 million yuan. Formerly known as Starmap Medicine, the company is a subsidiary of Haier Group and focuses on high-tech oncology equipment and cancer treatment. INKON Life Technology was incubated by Haier which currently holds a controlling stake of 40 percent of shares.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Everything on "Haier Group" in one document: edited and divided into chapters, including detailed references.
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield
Vice President, Hearst Magazines
China’s appliances market overview
Haier Smart Home financials
Revenue segments
Haier Biomedical & INKON Life Technology
Market share and sales
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
